Communiqués AcouSort AB

Actions

ACOU

SE0009189608

Temps Différé Nasdaq Stockholm Autres places de cotation 16:13:30 27/06/2024			Varia. 5j.	Varia. 1 janv.
13,55 ^SEK	-5,57%		-2,87%	-12,86%

22/05	AcouSort AB (publ) annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
02/05	AcouSort AB (publ) présentera deux posters soulignant la valeur de la préparation acoustique des échantillons	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

AcouSort to participate in a pioneering project to release the potential in extracellular vesicles research	05/06	AQ
AcouSort - Riding the acoustic wave	28/05	AQ
AcouSort selected by EIC for participation in BIO for the third time and also invited to showcase its solutions in ISCT’s Innovation Zone	24/05	AQ
AcouSort AB - Interim Report for the period January to March 2024	22/05	AQ
AcouSort will exhibit and present at CYTO 2024 – demonstrating the benefits of acoustic sample preparation for flow cytometry applications	02/05	AQ
Communiqué from the annual general meeting of AcouSort AB (publ)	30/04	AQ
AcouSort and Gensensor enter collaboration aiming at improving bioreactor culturing	29/04	AQ
AcouWash placed at two potential OEM partners	26/04	AQ
Increased interest for AcouTrap EV isolation for nano flow cytometry applications	04/04	AQ
AcouSort restructures its North American sales operation	03/04	AQ
AcouSort AB Annual report 2023	02/04	AQ
Shareholder interview with AcouSort’s CEO Torsten Freltoft and Commercial Director Agnes Michanek	13/03	AQ
Year end report for AcouSort AB 1 January - 31 December 2023	28/02	AQ
Significant technical progress in the AcouSome project – two novel patent applications filed	31/01	AQ
AcouSort extends collaboration with leading cell therapy company into a third project phase	18/01	AQ
AcouSort attends Advanced Therapies Week to extend its cell therapy network	16/01	AQ
AcouSort : The board of directors resolves to repurchase warrants series 2020/2023	19/12	PU
AcouSort's rights issue is registered - conversion of BTU into shares and warrants	12/12	AQ
FDA approval paves the way for AcouSort's first OEM commercialization within critical care diagnostics	11/12	AQ
AcouSort : rights issue fully subscribed	05/12	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués AcouSort AB

Actions

ACOU

SE0009189608

Communiqués

Filtres